SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-028525
Filing Date
2017-02-02
Accepted
2017-02-02 11:52:02
Documents
1
Group Members
COAST FUND L.P.COAST OFFSHORE MANAGEMENT (CAYMAN), LTD.SHAMUS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d299658dsc13ga.htm SC 13G/A 94272
  Complete submission text file 0001193125-17-028525.txt   95945
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54715 | Film No.: 17567393
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 LINDA FLORA DRIVE LOS ANGELES CA 90049
Business Address
Smith David E (Filed by) CIK: 0001378591 (see all company filings)

Type: SC 13G/A